What this does is remove the massive financial drain of research and development away from AHZ.
Wayne abandoning this R&D basically saved AHZ from financial ruin. Something I had called for on numerous occasions several years ago.
So we now have a 30% share in an asset that will not involve any investment from AHZ shareholders or AHZ company. Having 80% ,and not the means to finance immunotherapies , was not only worthless but potentially damaging.
This is a game changer.
What this does is remove the massive financial drain of research...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.00 |
Change
-0.150(0.99%) |
Mkt cap ! $317.0M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.10 | $14.85 | $133.6K | 8.912K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $14.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 510 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |